The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
DNA Repair Pathways in Clinical Practice: Lessons From Pediatric Cancer Susceptibility Syndromes
Abstract
Human cancers exhibit genomic instability and an increased mutation rate due to underlying defects in DNA repair. Cancer cells are often defective in one of six major DNA repair pathways, namely: mismatch repair, base excision repair, nucleotide excision repair, homologous recombination, nonhomologous endjoining and translesion synthesis. The specific DNA repair pathway affected is predictive of the kinds of mutations, the tumor drug sensitivity, and the treatment outcome. The study of rare inherited DNA repair disorders, such as Fanconi anemia, has yielded new insights to drug sensitivity and treatment of sporadic cancers, such as breast or ovarian epithelial tumors, in the general population. The Fanconi anemia pathway is an example of how DNA repair pathways can be deregulated in cancer cells and how biomarkers of the integrity of these pathways could be useful as a guide to cancer management and may be used in the development of novel therapeutic agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683
Instability and decay of the primary structure of DNA
Lindahl, T. (1993) · Nature · doi:10.1038/362709a0 · Cited by 5,679
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
Bryant, H. E., Schultz, N., Thomas, H. D., Parker, K. M., Flower, D., Lopez, E., Kyle, S., Meuth, M., Curtin, N. J., & Helleday, T. (2005) · Nature · doi:10.1038/nature03443 · Cited by 5,198
Genetic instabilities in human cancers
Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1998) · Nature · doi:10.1038/25292 · Cited by 4,168
Genome maintenance mechanisms for preventing cancer
Hoeijmakers, J. H. J. (2001) · Nature · doi:10.1038/35077232 · Cited by 3,939
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688
DNA double-strand breaks: signaling, repair and the cancer connection
Khanna, K. K., & Jackson, S. P. (2001) · Nature Genetics · doi:10.1038/85798 · Cited by 2,455
Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2
King, M.-C., Marks, J. H., & Mandell, J. B. (2003) · Science · doi:10.1126/science.1088759 · Cited by 2,229
Gene-Expression Profiles in Hereditary Breast Cancer
Hedenfalk, I., Duggan, D., Chen, Y., Radmacher, M., Bittner, M., Simon, R., Meltzer, P., Gusterson, B., Esteller, M., Raffeld, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102223440801 · Cited by 1,733
Hallmarks of 'BRCAness' in sporadic cancers
Turner, N., Tutt, A., & Ashworth, A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1457 · Cited by 1,657
Kane, M., Loda, M. F., Gaida, G. M., Lipman, J., Mishra, R., Goldman, H., Jessup, J. M., & Kolodner, R. D. (1997) · PubMed · Cited by 1,476
The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase η
Masutani, C., Kusumoto, R., Yamada, A., Dohmae, N., Yokoi, M., Yuasa, M., Araki, M., Iwai, S., Takio, K., & Hanaoka, F. (1999) · Nature · doi:10.1038/21447 · Cited by 1,292
Promoter Hypermethylation and BRCA1 Inactivation in Sporadic Breast and Ovarian Tumors
Esteller, M. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.7.564 · Cited by 1,233
Interaction of the Fanconi Anemia Proteins and BRCA1 in a Common Pathway
Garcia-Higuera, I., Taniguchi, T., Ganesan, S., Meyn, M. S., Timmers, C., Hejna, J., Grompe, M., & D'Andrea, A. D. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00173-3 · Cited by 1,198
Self-citationHypermutability and mismatch repair deficiency in RER+ tumor cells
Parsons, R., Li, G.-M., Longley, M. J., Fang, W.-H., Papadopoulos, N., Jen, J., de la Chapelle, A., Kinzler, K. W., Vogelstein, B., & Modrich, P. (1993) · Cell · doi:10.1016/0092-8674(93)90331-j · Cited by 1,053
BRCA2 Is Required for Homology-Directed Repair of Chromosomal Breaks
Moynahan, M. E., Pierce, A. J., & Jasin, M. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00174-5 · Cited by 1,006
The Fanconi anaemia/BRCA pathway
D'Andrea, A. D., & Grompe, M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc970 · Cited by 822
Self-citationRole of BRCA2 in Control of the RAD51 Recombination and DNA Repair Protein
Davies, A. A., Masson, J.-Y., McIlwraith, M. J., Stasiak, A. Z., Stasiak, A., Venkitaraman, A. R., & West, S. C. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00175-7 · Cited by 718
Bisphenol A Exposure Causes Meiotic Aneuploidy in the Female Mouse
Hunt, P. A., Koehler, K. E., Susiarjo, M., Hodges, C. A., Ilagan, A., Voigt, R. C., Thomas, S., Thomas, B. F., & Hassold, T. J. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00189-1 · Cited by 636
Chen, J., Silver, D. P., Walpita, D., Cantor, S. B., Gazdar, A. F., Tomlinson, G., Couch, F. J., Weber, B. L., Ashley, T., Livingston, D. M., et al. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80276-2 · Cited by 633
Association of BRCA1 with the hRad50-hMre11-p95 Complex and the DNA Damage Response
Zhong, Q., Chen, C.-F., Li, S., Chen, Y., Wang, C.-C., Xiao, J., Chen, P.-L., Sharp, Z. D., & Lee, W.-H. (1999) · Science · doi:10.1126/science.285.5428.747 · Cited by 626
A 20-year perspective on the International Fanconi Anemia Registry (IFAR)
Kutler, D. I., Singh, B., Satagopan, J., Batish, S. D., Berwick, M., Giampietro, P. F., Hanenberg, H., & Auerbach, A. D. (2003) · Blood · doi:10.1182/blood-2002-07-2170 · Cited by 618
DNA MISMATCH REPAIR AND GENETIC INSTABILITY
Harfe, B. D., & Jinks-Robertson, S. (2000) · Annual Review of Genetics · doi:10.1146/annurev.genet.34.1.359 · Cited by 608
UV-Induced Ubiquitylation of XPC Protein Mediated by UV-DDB-Ubiquitin Ligase Complex
Sugasawa, K., Okuda, Y., Saijo, M., Nishi, R., Matsuda, N., Chu, G., Mori, T., Iwai, S., Tanaka, K., Tanaka, K., et al. (2005) · Cell · doi:10.1016/j.cell.2005.02.035 · Cited by 576
A novel ubiquitin ligase is deficient in Fanconi anemia
Meetei, A. R., de Winter, J. P., Medhurst, A. L., Wallisch, M., Waisfisz, Q., van de Vrugt, H. J., Oostra, A. B., Yan, Z., Ling, C., Bishop, C. E., et al. (2003) · Nature Genetics · doi:10.1038/ng1241 · Cited by 568
DNA Ligase IV Mutations Identified in Patients Exhibiting Developmental Delay and Immunodeficiency
O'Driscoll, M., Cerosaletti, K. M., Girard, P.-M., Dai, Y., Stumm, M., Kysela, B., Hirsch, B., Gennery, A., Palmer, S. E., Seidel, J., et al. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00408-7 · Cited by 548
Disruption of the Fanconi anemia–BRCA pathway in cisplatin-sensitive ovarian tumors
Taniguchi, T., Tischkowitz, M., Ameziane, N., Hodgson, S. V., Mathew, C. G., Joenje, H., Mok, S. C., & D'Andrea, A. D. (2003) · Nature Medicine · doi:10.1038/nm852 · Cited by 536
Self-citationGenetic Polymorphisms in the Base Excision Repair Pathway and Cancer Risk: A HuGE Review
Hung, R. J., Hall, J., Brennan, P., & Boffetta, P. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi318 · Cited by 525
Deficient DNA mismatch repair: a common etiologic factor for colon cancer
Peltomaki, P. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.7.735 · Cited by 505
Loss of DNA mismatch repair in acquired resistance to cisplatin.
Aebi, S. P., Kurdi-Haidar, B., Gordon, R. T., Cenni, B., Zheng, H., Fink, D. A., Christen, R. D., Boland, C. R., Koi, M., Fishel, R. A., et al. (1996) · PubMed · Cited by 502
DNA repair-deficient diseases, xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy
Lehmann, A. (2003) · Biochimie · doi:10.1016/j.biochi.2003.09.010 · Cited by 496
BRCA2 germline mutations in familial pancreatic carcinoma
Hahn, S. A., Greenhalf, B., Ellis, I., Sina-Frey, M., Rieder, H., Korte, B., Gerdes, B., Kress, R., Ziegler, A., Raeburn, J. A., et al. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.3.214 · Cited by 480
BRCA2 is required for ionizing radiation-induced assembly of Rad51 complex in vivo.
Yuan, S. F., Lee, S. Y., Chen, G., Song, M., Tomlinson, G. E., & Lee, E. Y.-H. P. (1999) · PubMed · Cited by 474
The Fanconi Anemia/BRCA pathway: new faces in the crowd
Kennedy, R. D., & D'Andrea, A. D. (2005) · Genes & Development · doi:10.1101/gad.1370505 · Cited by 467
Self-citationS-phase–specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51
Taniguchi, T., Garcia-Higuera, I., Andreassen, P. R., Gregory, R. C., Grompe, M., & D'Andrea, A. D. (2002) · Blood · doi:10.1182/blood-2002-01-0278 · Cited by 461
Self-citationThe role of DNA mismatch repair in drug resistance
Nebel, S. (1998) · ETH Zürich Research Collection · doi:10.3929/ethz-a-001915508 · Cited by 461
Subpathways of nucleotide excision repair and their regulation
Hanawalt, P. C. (2002) · Oncogene · doi:10.1038/sj.onc.1206096 · Cited by 447
Improved survival in women with BRCA‐associated ovarian carcinoma
Cass, I., Baldwin, R. L., Varkey, T., Moslehi, R., Narod, S. A., & Karlan, B. Y. (2003) · Cancer · doi:10.1002/cncr.11310 · Cited by 433
The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J
Levitus, M., Waisfisz, Q., Godthelp, B. C., Vries, Y. D., Hussain, S., Wiegant, W. W., Elghalbzouri-Maghrani, E., Steltenpool, J., Rooimans, M. A., Pals, G., et al. (2005) · Nature Genetics · doi:10.1038/ng1625 · Cited by 432
Cancer in Fanconi anemia, 1927–2001
Alter, B. P. (2003) · Cancer · doi:10.1002/cncr.11046 · Cited by 432
Furuta, T., Ueda, T., Aune, G. J., Sarasin, A. R., Kraemer, K. H., & Pommier, Y. G. (2002) · PubMed · Cited by 422
Cancer Risks for Male Carriers of Germline Mutations in BRCA1 or BRCA2: A Review of the Literature
Liede, A., Karlan, B. Y., & Narod, S. A. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.055 · Cited by 407
Identification of a defect in DNA ligase IV in a radiosensitive leukaemia patient
Riballo, E., Critchlow, S. E., Teo, S.-H., Doherty, A. J., Priestley, A., Broughton, B., Kysela, B., Beamish, H., Plowman, N., Arlett, C. F., et al. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80311-x · Cited by 400
Litman, R., Peng, M., Jin, Z., Zhang, F., Zhang, J., Powell, S., Andreassen, P. R., & Cantor, S. B. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.08.004 · Cited by 396
Trading Places: How Do DNA Polymerases Switch during Translesion DNA Synthesis?
Friedberg, E. C., Lehmann, A. R., & Fuchs, R. P. P. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.03.032 · Cited by 375
The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia
Levran, O., Attwooll, C., Henry, R. T., Milton, K. L., Neveling, K., Rio, P., Batish, S. D., Kalb, R., Velleuer, E., Barral, S., et al. (2005) · Nature Genetics · doi:10.1038/ng1624 · Cited by 370
High Incidence of Head and Neck Squamous Cell Carcinoma in Patients With Fanconi Anemia
Kutler, D. I., Auerbach, A. D., Satagopan, J., Giampietro, P. F., Batish, S. D., Huvos, A. G., Goberdhan, A., Shah, J. P., & Singh, B. (2003) · Archives of Otolaryngology–Head & Neck Surgery · doi:10.1001/archotol.129.1.106 · Cited by 370
Relevance of DNA methylation in the management of cancer
Esteller, M. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01115-x · Cited by 329
Hardeland, U., Steinacher, R., Jiricny, J., & Schär, P. (2002) · The EMBO Journal · doi:10.1093/emboj/21.6.1456 · Cited by 319
The Fanconi Anaemia Gene FANCC Promotes Homologous Recombination and Error-Prone DNA Repair
Niedzwiedz, W., Mosedale, G., Johnson, M., Ong, C. Y., Pace, P., & Patel, K. J. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.08.009 · Cited by 308
BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer
Taron, M., Rosell, R., Felip, E., Mendez, P., Souglakos, J., Ronco, M. S., Queralt, C., Majo, J., Sanchez, J. M., Sanchez, J. J., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh260 · Cited by 307
Köberle, B., Masters, J. R. W., Hartley, J. A., & Wood, R. D. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80118-3 · Cited by 300
Gurubhagavatula, S., Liu, G., Park, S., Zhou, W., Su, L., Wain, J. C., Lynch, T. J., Neuberg, D. S., & Christiani, D. C. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.067 · Cited by 292
Zhou, W., Gurubhagavatula, S., Liu, G., Park, S., Neuberg, D. S., Wain, J. C., Lynch, T. J., Su, L., & Christiani, D. C. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0247 · Cited by 291
Leukemia and preleukemia in Fanconi anemia patients
Auerbach, A. D., & Allen, R. G. (1991) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(91)90002-c · Cited by 257
CpG Island Methylation of DNA Damage Response Genes in Advanced Ovarian Cancer
Teodoridis, J. M., Hall, J., Marsh, S., Kannall, H. D., Smyth, C., Curto, J., Siddiqui, N., Gabra, H., McLeod, H. L., Strathdee, G., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1187 · Cited by 256
The overexpression of specialized DNA polymerases in cancer
Albertella, M. R., Lau, A., & O’Connor, M. J. (2005) · DNA Repair · doi:10.1016/j.dnarep.2005.01.005 · Cited by 250
Nijmegen breakage syndrome: clinical manifestation of defective response to DNA double-strand breaks
Digweed, M., & Sperling, K. (2004) · DNA Repair · doi:10.1016/j.dnarep.2004.03.004 · Cited by 250
Trivedi, R. N., Almeida, K. H., Fornsaglio, J. L., Schamus, S., & Sobol, R. W. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0715 · Cited by 242
Cantor, S., Drapkin, R., Zhang, F., Lin, Y., Han, J., Pamidi, S., & Livingston, D. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308717101 · Cited by 240
Effect of DNA lesions on transcription elongation
Tornaletti, S., & Hanawalt, P. C. (1999) · Biochimie · doi:10.1016/s0300-9084(99)80046-7 · Cited by 235
Marsit, C. J., Liu, M., Nelson, H. H., Posner, M., Suzuki, M., & Kelsey, K. T. (2004) · Oncogene · doi:10.1038/sj.onc.1207256 · Cited by 228
Moshous, D., Pannetier, C., Chasseval, R. D., Deist, F. L., Cavazzana-Calvo, M., Romana, S., Macintyre, E., Canioni, D., Brousse, N., Fischer, A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16774 · Cited by 227
Narayan, G., Arias‐Pulido, H., Koul, S., Vargas, H., Zhang, F. F., Villella, J., Schneider, A., Terry, M. B., MANSUKHANI, M. M., & Murty, V. V. V. S. (2003) · Molecular Cancer · doi:10.1186/1476-4598-2-24 · Cited by 218
Inactivation of BRCA1 and BRCA2 in Ovarian Cancer
Hilton, J. L. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.18.1396 · Cited by 218
The DNA‐dependent protein kinase: the director at the end
Meek, K., Gupta, S., Ramsden, D. A., & Lees‐Miller, S. P. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00162.x · Cited by 213
Bridge, W. L., Vandenberg, C. J., Franklin, R. J., & Hiom, K. (2005) · Nature Genetics · doi:10.1038/ng1627 · Cited by 211
Chk2 Activation Dependence on Nbs1 after DNA Damage
Buscemi, G., Savio, C., Zannini, L., Miccichè, F., Masnada, D., Nakanishi, M., Tauchi, H., Komatsu, K., Mizutani, S., Khanna, K., et al. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.15.5214-5222.2001 · Cited by 201
Shared Genetic Susceptibility to Breast Cancer, Brain Tumors, and Fanconi Anemia
Offit, K., Levran, O., Mullaney, B., Mah, K., Nafa, K., Batish, S. D., Diotti, R., Schneider, H., Deffenbaugh, A., Scholl, T., et al. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg072 · Cited by 201
Hirsch, B., Shimamura, A., Moreau, L., Baldinger, S., Hag-alshiekh, M., Bostrom, B., Sencer, S., & D'Andrea, A. D. (2004) · Blood · doi:10.1182/blood-2003-06-1970 · Cited by 199
Self-citationRobertson, K. A., Bullock, H. A., Xu, Y., Tritt, R., Zimmerman, E., Ulbright, T. M., Foster, R. S., Einhorn, L. H., & Kelley, M. R. (2001) · PubMed · Cited by 194
Promoter Hypermethylation of FANCF
Narayan, G., Arias-Pulido, H., Nandula, S. V., Basso, K., Sugirtharaj, D. D., Vargas, H., Mansukhani, M., Villella, J., Meyer, L., Schneider, A., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0245 · Cited by 190
Nojima, K., Hochegger, H., Saberi, A., Fukushima, T., Kikuchi, K., Yoshimura, M., Orelli, B. J., Bishop, D. K., Hirano, S., Ohzeki, M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1214 · Cited by 185
Genetic interaction between PARP and DNA-PK in V(D)J recombination and tumorigenesis
Morrison, C., Smith, G. C. M., Stingl, L., Jackson, S. P., Wagner, E. F., & Wang, Z.-Q. (1997) · Nature Genetics · doi:10.1038/ng1297-479 · Cited by 176
Stoehlmacher, J., Ghaderi, V., Iobal, S., Groshen, S. G., Tsao-Wei, D. D., Park, D., & Lenz, H. (2001) · PubMed · Cited by 172
Polymorphisms in DNA Base Excision Repair Genes ADPRT and XRCC1 and Risk of Lung Cancer
Zhang, X., Miao, X., Liang, G., Hao, B., Wang, Y., Tan, W., Li, Y., Guo, Y., He, F., Wei, Q., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.722.65.3 · Cited by 170
Hypersensitivity of Nonhomologous DNA End-joining Mutants to VP-16 and ICRF-193
Adachi, N., Suzuki, H., Iiizumi, S., & Koyama, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306500200 · Cited by 169
NBS1 Is a Prostate Cancer Susceptibility Gene
Cybulski, C., Górski, B., Dębniak, T., Gliniewicz, B., Mierzejewski, M., Masojć, B., Jakubowska, A., Matyjasik, J., Złowocka, E., Sikorski, A., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2502 · Cited by 164
A significant response to neoadjuvant chemotherapy in BRCA1/2 related breast cancer: Table 1
Chappuis, P. O., Goffin, J., Wong, N., Perret, C., Ghadirian, P., Tonin, P. N., & Foulkes, W. D. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.8.608 · Cited by 156
In vivoTherapeutic Responses Contingent on Fanconi Anemia/BRCA2 Status of the Tumor
van der Heijden, M. S., Brody, J. R., Dezentjé, D. A., Gallmeier, E., Cunningham, S. C., Swartz, M. J., Marzo, A. M. D., Offerhaus, G. J. A., Isacoff, W. H., Hruban, R. H., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1048 · Cited by 150
RAD18 and RAD54 cooperatively contribute to maintenance of genomic stability in vertebrate cells
Yamashita, Y. M., Okada, T., Matsusaka, T., Sonoda, E., Zhao, G. Y., Araki, K., Tateishi, S., Yamaizumi, M., & Takeda, S. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf534 · Cited by 149
Germ Line Fanconi Anemia Complementation Group C Mutations and Pancreatic Cancer
Couch, F. J., Johnson, M. R., Rabe, K. G., Boardman, L., McWilliams, R. R., de Andrade, M., & Petersen, G. M. (2005) · Cancer Research · doi:10.1158/0008-5472.383.65.2 · Cited by 146
Role of promoter hypermethylation in Cisplatin treatment response of male germ cell tumors.
Koul, S., McKiernan, J. M., Narayan, G., Houldsworth, J., Bacik, J., Dobrzynski, D. L., Assaad, A. M., MANSUKHANI, M. M., Reuter, V. E., Bosl, G. J., et al. (2004) · Molecular Cancer · doi:10.1186/1476-4598-3-16 · Cited by 139
Functional Defects in the Fanconi Anemia Pathway in Pancreatic Cancer Cells
van der Heijden, M. S., Brody, J. R., Gallmeier, E., Cunningham, S. C., Dezentjé, D. A., Shen, D., Hruban, R. H., & Kern, S. E. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63329-9 · Cited by 129
Dependence of the Cytotoxicity of DNA-Damaging Agents on the Mismatch Repair Status of Human Cells
Papouli, E., Ćejka, P., & Jiricny, J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0513 · Cited by 128
Jin, Y., Chen, Z., Liu, Y., Hickey, R. J., & Malkas, L. H. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0603 · Cited by 127
O‐Wang, J., Kawamura, K., Tada, Y., Ohmori, H., Kimura, H., Sakiyama, S., & Tagawa, M. (2001) · PubMed · Cited by 121
BRCA1 : mechanisms of inactivation and implications for management of patients
Kennedy, R. D., Quinn, J. E., Johnston, P. G., & Harkin, D. P. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11087-7 · Cited by 116
Self-citationKomuro, Y., Watanabe, T., Hosoi, Y., Matsumoto, Y., Nakagawa, K., Tsuno, N. H., Kazama, S., Kitayama, J., Suzuki, N., & Nagawa, H. (2002) · Cancer · doi:10.1002/cncr.10807 · Cited by 94
Modulation of Cell Cycle Components by Epigenetic and Genetic Events
Macaluso, M., Montanari, M., Cinti, C., & Giordano, A. (2005) · Seminars in Oncology · doi:10.1053/j.seminoncol.2005.07.009 · Cited by 94
Deletion and reduced expression of the Fanconi anemia FANCA gene in sporadic acute myeloid leukemia
Tischkowitz, M. D., Morgan, N. V., Grimwade, D. J., Eddy, C.-A., Ball, S. E., Vořechovský, I., Langabeer, S. E., Stöger, R. J., Hodgson, S. V., & Mathew, C. G. (2004) · Leukemia · doi:10.1038/sj.leu.2403280 · Cited by 91
Dhillon, V. S., Shahid, M., & Husain, S. A. (2004) · Molecular Cancer · doi:10.1186/1476-4598-3-33 · Cited by 89
Calabrese, C. R., Batey, M. A., Thomas, H. D., Durkacz, B. W., Wang, L.-Z., Kyle, S., Skalitzky, D. J., Li, J., Zhang, C. R., Boritzki, T. J., et al. (2003) · PubMed · doi:10.25405/ncl.34611858 · Cited by 78
Modulation of Cellular Response to Cisplatin by a Novel Inhibitor of DNA Polymerase β
Boudsocq, F., Benaim, P., Canitrot, Y., Knibiehler, M., Ausseil, F., Capp, J., Bieth, A., Long, C., David, B., Shevelev, I., et al. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.001776 · Cited by 56
Fiumicino, S., Martinelli, S., Colussi, C., Aquilina, G., Leonetti, C., Crescenzi, M., & Bignami, M. (2000) · International Journal of Cancer · Cited by 53
Rigas, B., Borgo, S., Elhosseiny, A. A., Balatsos, V. E., Manika, Z., Shinya, H., Kurihara, N., Go, M., & Lipkin, M. (2001) · PubMed · Cited by 49
Bavoux, C., Hoffmann, J., & Cazaux, C. (2005) · Biochimie · doi:10.1016/j.biochi.2005.02.007 · Cited by 49
Zanier, R., Briot, D., du Villard, J.-A. D., Sarasin, A. R., & Rosselli, F. (2004) · Oncogene · doi:10.1038/sj.onc.1207677 · Cited by 48
Aberrant Fanconi anaemia protein profiles in acute myeloid leukaemia cells
Xie, Y., de Winter, J. P., Waisfisz, Q., Nieuwint, A. W. M., Scheper, R. J., Arwert, F., Hoatlin, M. E., Ossenkoppele, G. J., Schuurhuis, G., & Joenje, H. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02450.x · Cited by 43
Kanamori, M., Kon, H., Nobukuni, T., Nomura, S., Sugano, K., Mashiyama, S., Kumabe, T., Yoshimoto, T., Meuth, M., Sekiya, T., et al. (2000) · Oncogene · doi:10.1038/sj.onc.1203454 · Cited by 42
Analysis of the Fanconi Anaemia Complentation Group A Gene in Acute Myeloid Leukaemia
Condie, A., Powles, R., Hudson, C. D., Shepherd, V., Bevan, S., Yuille, M., & Houlston, R. S. (2002) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/1042819021000009274 · Cited by 36
Cited by
Stratton, M. R., Campbell, P. J., & Futreal, P. A. (2009) · Nature · doi:10.1038/nature07943 · Cited by 3,449
Genomic instability — an evolving hallmark of cancer
Negrini, S., Gorgoulis, V. G., & Halazonetis, T. D. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2858 · Cited by 2,397
Mechanism of Eukaryotic Homologous Recombination
San Filippo, J., Sung, P., & Klein, H. (2008) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.77.061306.125255 · Cited by 1,681
Repair Pathway Choices and Consequences at the Double-Strand Break
Ceccaldi, R., Rondinelli, B., & D’Andrea, A. D. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.07.009 · Cited by 1,499
Self-citationGenomic and Epigenetic Instability in Colorectal Cancer Pathogenesis
Grady, W. M., & Carethers, J. M. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.07.076 · Cited by 960
Metadata
- Authors
- Kennedy, R. D., & D'Andrea, A. D.
- Venue
- Journal of Clinical Oncology
- Published
- 2006-08-10
- Volume
- 24
- Issue
- 23
- Pages
- 3799-3808
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2125732268
- Cited by
- 286
- References
- 103
- FWCI
- 7.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.